Maryland Stem Cell Research Fund awards 1st round of $8.2M funding initiative: 5 things to know

Shayna Korol -   Print  |

Maryland Technology Development Corp., awarded the first two grants from the state's Stem Cell Research Fund, Baltimore Business Journal reports.

Here are five things to know:

1. Maryland's Stem Cell Research Fund is designed to accelerate research and commercialization of stem cell therapies. To date, the fund has committed more than $147 million to over 430 research projects.

2. All sponsored projects must involve human stem cells and be conducted in Maryland.

3. The two awards totaled around $530,000.

4. CEO of Gemstone Biotherapeutics Emily English, PhD, received a commercialization award of $299,998. This award is intended to help with the creation of startup companies or new technologies developed in Maryland-based firms.

5. Sharon Gerecht, PhD, of Baltimore-based Johns Hopkins University received a $230,000 validation award, which is intended to help transition promising stem cell technologies with commercial potential from universities and research labs to the commercial sector.

More articles on biologics:
5 things to know about the global orthobiologics market
Kuros Biosciences appoints 5 spine surgeons to advisory board
Orthopedic surgeon named Reinvent Biologics' CMO: 3 insights

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers